LO

Leighanne Oh

Investor at Ascenta Capital

United States

Overview 

Leighanne Oh is a Biotech Investor with a background in healthcare investment banking and engineering. She has held roles at prestigious firms like Novo Holdings and Sofinnova Investments, and has experience in advanced manufacturing and operations engineering at GE Healthcare.

Work Experience 

  • Investor

    2024 - Current

    https://ascentacap.com/

Ascenta Capital is a private equity and venture capital firm.

  • Investor

    2022 - 2024

    Novo Holdings is a healthcare permanent capital fund investing in private and public companies, making it one of the most active life sciences venture capital investors globally. As of 2024, Novo Holdings was managing $147bn in total AUM with an annual capital deployment target of $3bn.

  • Investor

    2019 - 2022

    Founded in 1976, Sofinnova is a clinical-stage biopharmaceutical investment firm with approximately $3.0B in AUM and committed capital investing in both private and public equity of therapeutics-focused companies.

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

  • Healthcare Investment Banking

    2017 - 2019

  • Advanced Manufacturing / Operations Engineer

    2016 - 2016

    MRI Gradient Coils and Shimming Optimization

GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers.

Raised $5,524,660,836.00 from Bill & Melinda Gates Foundation.

  • Investment Banking Analyst

    2014 - 2015

    https://www.linkedin.com/pulse/owen-may-mba-83-lives-his-values-through-leadership-/

Mdgpartners is a financial consultancy firm that offers services such as private funds, capital markets and independent advisory,

  • Howard Hughes Research Fellow

    2009 - 2011

  • Research Analyst

    2010 - 2011

Articles About Leighanne

Relevant Websites